| ATNF Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATNF shares outstanding history going back to 8/19/2020:
Also see: ATNF Market Cap History ATNF YTD Return |
As of 7/22/2025 180 Life Sciences has 6.04 million ATNF shares outstanding. Investors often track the ATNF shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ATNF share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 8/19/2020.

| ATNF Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATNF shares outstanding history going back to 8/19/2020:
Also see: ATNF Market Cap History ATNF YTD Return |
| ATNF Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
ATNF Historical Shares Outstanding: +240.69% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| ATNF Stock Price Chart |
| About ETHZilla Corp |
| 180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Co. is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). Co. has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). We show 21 historical shares outstanding datapoints in our coverage of ATNF's shares outstanding history. Understanding the changing numbers of ATNF shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ATNF versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ATNF by allowing them to research ATNF shares outstanding history as well as any other stock in our coverage universe. |
| ATNF Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ATNF Share Performance |
| Shares Outstanding Peers |
| 180 Life Sciences (ATNF) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ATNX Shares Outstanding History ATOS Shares Outstanding History ATRA Shares Outstanding History ATRC Shares Outstanding History ATRI Shares Outstanding History ATRS Shares Outstanding History ATXI Shares Outstanding History ATXS Shares Outstanding History ATYR Shares Outstanding History AURA Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.